Press ReleasesRecent Press ReleasesFor information regarding press releases please contact us at:
Phone: (402) 452-5437
Fax: (402) 452-5461
E-mail: investorrelations@transgenomic.com DisclaimerThe following historical press releases contain statements that reflected management's views and estimates of future economic circumstances, industry conditions, company performance and financial results applicable on the dates they were first issued. Investors should not assume that statements made in these documents remain accurate and complete as of any later date. Such statements were and remain subject to certain factors, risks and uncertainties, including those described in Transgenomic, Inc.'s reports to the Securities and Exchange Commission. Any change in such factors, risks and uncertainties could have caused the actual results, events and performance to differ materially from those referred to in such statements. Transgenomic expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any of these documents to reflect any change in Transgenomic's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements were based. Recent Releases| May 8, 2012 | View | Transgenomic Reports First Quarter 2012 Financial Results | | | | May 8, 2012 | View | Reminder: Transgenomic to Hold First Quarter Financial Results Conference Call Today | | | | May 1, 2012 | View | Transgenomic to Hold First Quarter Financial Results Conference Call on May 8, 2012 | | | | March 30, 2012 | View | Transgenomic, Inc. Announces Presentation of Results from 448-Gene NuclearMitome Test in 78 Patients at the 2012 Annual Meeting of the American College of Medical Genetics | | | | March 20, 2012 | View | Transgenomic and MD Anderson Collaborate on Circulating Tumor Cell Study using ICE COLD-PCR | | |
|